Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Pargluva Goes Down? | Main | Five Questions »

October 30, 2005

Gooooaaaal!

Email This Entry

Posted by Derek

I do a fair amount of complaining (maybe I could just stop and put a period there. No?) about how people don't realize the difficulty of taking an idea for a new drug all the way to the market. But I shouldn't be the tiniest bit surprised, because depictions of research skip most of the work. How would anyone who doesn't do this stuff realize how time-consuming it is?

When I started doing real lab experiments, it struck me that I was spending an awful long time purifying messy reaction mixtures and trying to make sure that I'd made what I thought I'd made. Now, twenty-odd years later, it seems like I spend a awful lot of time doing those same things. There's no way around either one of them, but you'd never know it from virtually any depiction of scientists at work. Having a character spend three days running a chromatography over again (and again) because the peaks aren't well resolved doesn't advance the plot very well, does it? There's nothing page-turning about combining a long run of messy mixed fractions, evaporating out all the solvent - which always takes much longer than you thing it will - and sending them down yet another column, which will generate a few pure cuts and another heap of mixed fractions.

These delays are found in every operation of a research lab, and they scale in a fractal-type manner. Five-minute tasks have at least a minute's worth of delay in them (waiting for the thick syrupy starting material to dissolve so you can toss a magnetic stir bar in there without getting it stuck), and five-month tasks have at least a month's worth (figuring out why the large batch of material for the serious toxicology runs doesn't dissolve as well in the dosing vehicle as all the other batchs). And the five-year tasks? Try an extra year of enrollment for the pivotal clinical trials on for size.

So asking a drug researcher how they could have worked for X years without ever producing a drug is a bit like asking a soccer team: "You booted that ball around the field for ninety minutes and didn't even put the thing in the net?" Nothing plays defense like nature can.

Comments (4) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

1. Marc on October 31, 2005 8:52 AM writes...

The misunderstanding lies in what you said last week in 'October 24, 2005 Hype or Hope?'

I think that most people do (or would) understand that it is a long and tedious process. But we (define we as you wish) keep telling them that we have had a major breakthrough. They are constantly lead the beleive the guys in the labcoats have finally finished most of the work.

But they do understand that there is a reason why they wear labcoats, and why they keep wearing them, even after so many years.

Permalink to Comment

2. milo on October 31, 2005 11:33 AM writes...

Nothin' beats getting an NMR only find that you need to run yet another column...

Permalink to Comment

3. Timothy on November 3, 2005 9:59 AM writes...

I think when people hear "major breakthrough" they automatically think "miracle drug" due to any number of cultural factors (media hype, ignorance of the scientific process, etc), when the case might actually be that the major breakthrough is but one more step toward something useful.

It isn't medicine, but look at the recent building of nanocars. That's a major achievement for science, but most people are going to go "So, they build a molecule that rolls around, what's it good for?"

Permalink to Comment

4. Dave on November 4, 2005 12:06 PM writes...

I'm a electrical engineer who does design work in a government laboratory, and I run into the same kinds of issues every day.

Should I spend my time fixing my equipment, or delving into creating more functionality? Some would say "oh, that sort of work is for a technican", yet, I have yet to find a technican who is able to achieve my standards for how the equipment ought to operate and how the lab ought to be arranged.

The "fun stuff" is the good part of the job, but there is certainly a great amount of "grunt work" that goes into any good design, and I think that is the crux of the matter. When you produce a successful design, it can appear to others that you spend your time working only on that design.

I think with any technical endeavour, most of the "real time" is spent dealing with the millions of details that have to be done just right in order to accomplish anything. If you are going to produce a design that is on the edge of what is possible, then every minor detail is going to have to be dealt with by the same team who is trying to push the edge.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
More on the NIH's Molecular Libraries Program
Inside A Chinese Pharmaceuticals Maker
Is the Research Works Act Dead?
Pseudephedrine Made Easy. Kind of.
An Actual Motivational Poster
Independent Inventions
The Worst Compound You've Ever Drawn?
Remember When We Were Going to Eliminate Deaths from Cancer?